LTE PARTNERS, LLC purchased 3.4% of their position (65K shares) of PROGENICS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $307.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/9/2019ACC: 0000921895-19-002384
10% OwnerOther
Since Aug 2019
+65K
Net shares
Net buyer
$307.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
65K acquired
Non-Derivative Transactions2
Common Stock, $0.0013 par value
Direct
Shares
+43.52K
Price / share
$4.62
Trade value
$201.10K
% of position
2.3%
9/5/2019
1.89M→1.93M
Common Stock, $0.0013 par value
Direct
Shares
+21.48K
Price / share
$4.94
Trade value
$106.10K
% of position
1.1%
9/9/2019
1.93M→1.95M
Total
Net shares
+65K
Net value
$307.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0013 par value Direct | 9/5/2019 | P · Purchase | +43.52K | $4.62 | $201.10K | 2.3% | 1.89M | 1.93M |
| Common Stock, $0.0013 par value Direct | 9/9/2019 | P · Purchase | +21.48K | $4.94 | $106.10K | 1.1% | 1.93M | 1.95M |
| Total | +65K | $307.19K | ||||||
Derivative Transactions0
No derivative transactions reported